Do cardiovascular risk factors modify the cardiotoxicity of lymphoma treatments?

Paul Anthony Wender

Synthetic Studies Related to Cancer Research/Treatment

Hodgkin lymphoma Non-Hodgkin lymphoma

Christopher S Carlson

Monitoring disease progression in follicular lymphoma with next-gen sequencing

Non-Hodgkin lymphoma

Pathology

Dean W Felsher

Prognostic Metabolic Signatures of Cancers Through Mass Spectrometry Imaging

Hodgkin lymphoma Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Corey Casper

Uganda Cancer Institute / Hutchinson Center Cancer Alliance (UCI/HCCA)

Hodgkin lymphoma Non-Hodgkin lymphoma

Franziska Michor

Evolution and Treatment Response of Brain, Breast, and Hematologic Malignancies

Hodgkin lymphoma Non-Hodgkin lymphoma

Brenda Marie Sandmaier

Alpha Radioimmunotherapy for Lymphoma Treatment

Non-Hodgkin lymphoma Hodgkin lymphoma

Martha Lassiter

2012 Tata Memorial Hospital Bone Marrow Transplant Program in Kolkata, India

Hodgkin lymphoma

Hematology and hematologic malignancies

Manoj Menon

AMC PROTOCOL #075: A Sequential Phase I/Randomized Phase II Trial of Vorinostat and Risk-Adapted Chemotherapy with Rituximab in HIV-Related B-Cell Non-Hodgkin’s Lymphoma. A Trial of the AIDS Malignancy Consortium (AMC)

Hodgkin lymphoma

Hematology and hematologic malignancies

Melinda Sue Butschkovacic

Fanconi Anemia as a Model for Susceptibility to Human Papillomavirus Infection

Hodgkin lymphoma Non-Hodgkin lymphoma